Major breast cancer screening AI trial to begin

A significant new trial is set to begin in the UK, focusing on the use of artificial intelligence, or AI, in breast cancer screenings. This ambitious study aims to recruit nearly 700,000 women across the country to participate in testing five different AI platforms at 30 locations starting in April. The primary objective of this trial is to determine whether AI can expedite the diagnosis of breast cancer and alleviate some of the workload faced by radiologists. This initiative coincides with the government's efforts to gather evidence and insights to help shape a national cancer plan, which is expected to be unveiled later this year. AI technology is already being utilized in various capacities within the NHS, including assisting in cancer treatment, managing patient waiting lists, and analyzing cancer scans. However, this trial represents the largest undertaking to date specifically targeting breast cancer detection. Women who have already scheduled their routine NHS screenings will be invited to participate in the £11 million Early Detection using Information Technology in Health (Edith) trial. The screening program is designed for women aged 50 to 53, who will receive screenings every three years until they reach the age of 71. During these appointments, mammograms, which are specialized X-rays, are performed to identify cancers that may be too small to detect through physical examination. Currently, two radiologists are required to review the images from each screening to ensure accuracy. The hope is that the AI being tested will enable one specialist to complete this task, thereby allowing radiologists to see more patients and ultimately reduce waiting times. With over two million mammograms conducted annually under the screening program, the potential impact on the workload of radiologists could be substantial. Professor Lucy Chappell, the chief scientific adviser for the Department of Health and Social Care, expressed optimism about the study, stating that it could represent a significant advancement in cancer care. Health Secretary Wes Streeting echoed this sentiment, emphasizing that this initiative should mark the beginning of broader improvements in cancer treatment. He highlighted the urgent need for action, noting that cancer survival rates in the UK are lagging behind those of other countries. He committed to publishing a dedicated national cancer plan aimed at positioning the UK as a leader in saving lives from this deadly disease. As part of this effort, the government has initiated a call for evidence, encouraging patients, healthcare staff, and experts to share their ideas and suggestions. However, Dr. Katharine Halliday, president of the Royal College of Radiologists, cautioned that while AI holds immense potential, the NHS is still facing a shortage of radiologists, currently estimated at 30%. She emphasized that this study will take time to produce results and that addressing the need for more radiology professionals remains a pressing concern.